| Tag | Content |
|---|
EnhancerAtlas ID | HS197-03725 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr11:47880050-47881810 |
Target genes | | Number: 12 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MAFK | MA0496.2 | chr11:47881687-47881706 | TACAGTTGACTCAGCAATT | + | 6.01 | | MAFK | MA0496.2 | chr11:47881687-47881706 | TACAGTTGACTCAGCAATT | - | 6.3 | | Nr2f6(var.2) | MA0728.1 | chr11:47880935-47880950 | GAGGTCAGGAGTTCA | + | 6.22 | | SOX10 | MA0442.2 | chr11:47881293-47881304 | AAAACAAAGGA | + | 6.32 | | Sox3 | MA0514.1 | chr11:47881293-47881303 | AAAACAAAGG | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_34706 | chr11:47876807-47887461 | HeLa | | SE_59342 | chr11:47871465-47957002 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I047853 | chr11 | 47874915 | 47887293 |
|
Enhancer Sequence | GTCTAAAGAC CACAGGGGCA AGGAAATGAA CTTTCTTGGG ATACCACAGA CCACTTAACA 60
GAAAATGTGC CCTTTGTTCT CATTCAAATG CCTTTTCCTT AAATGATATT TCTTTTCTTT 120
TTTTTGAGAC AGAGTCTTGC TCTGTCACCT AGGCTGGAGT GCAGTGGCAT GATCTCAGCT 180
CACTGCAACC TCTGCCTCCC AGGTTCAAGC GATTCTCCTG CCTCAGCCTC CCGAGTAGCT 240
GGGATTACAG GCGTCCACCA CCATGCCTGG CTAATTTTTG TGTTTTTAGT AGAGGCAGGG 300
TTTCACCATG TTGGCCAGGC TAGTCTCCAA CTCCTGACCT CAGGTGATCC CCCCGACCTT 360
GGGCTCCCCA AATGCTGGGA TTACAGGCAT GAGCCACCGT GCCCGGCCTC CTTAAATGAT 420
ATTTCTAAGG TTTCCTCAGA TCTATCTGCA CTAACTACTT GATTTTTCCT AGGTGCCTGT 480
CAGAAGACTA AAAGGAGGCA TTGGAATTCT GAATTTTCTG ATTAGAAAGC AGTAGCTCAC 540
CGTAATCCCA GCACTTTGGG AGGCTGAGGT GGGTGGATCA TTTGAGGTCA GGAGTTTGAG 600
ACCAGCCTGG CCAAAATGGT GAAACCCCGT CTCTACTAAA AATACAAAAA ATAGCCGGGT 660
GTGATGGCAG GCACCTGTAA TCCCAGCTAC TTGGGAGGCT GAGGCAGGAG AATCTCTTGA 720
ATCTGGGAGA TGGAGGTTAC AGTGAGCCAA GATCATGCCA CTGCACTCCA GCCTGGGTGA 780
CAAAGCAAGA CTCTGACTCA AAAAAAAAAA AAAAAAAAAA AGGCCAGGTG CGGGGGCTCA 840
CCCTTGTAAT CCCAGCACTT TGGGAGGCCA AGGCGGGTGG ATCATGAGGT CAGGAGTTCA 900
AGACCAGCCT GACCAACATG GTGAAACCCA GTCTCTACTA AAAATACAAA AATTAGCCAG 960
GTGTAGTGGT GTGTGCCTGT AATCCCAGCT ACTTAGTAAG CTGAGTCAGG AGAATTGCTT 1020
GAACCCGGGA GGCGGAGGTT GCAATGAGCT GAGATCATGC CACTGCACTC CAGCCTGGGC 1080
GACAGAGTGA GACTCTGTCT CAAAAAAAAA AAAAAAAAAG AAAGGAGTAC CTCAAAAAGA 1140
AAAAGTGATT TGCCCAGGCA TTTAGTCAGG CAATTCTATT AGTTGTGTCT GAATCCATTC 1200
TTTAAACATT TTAAAATGCT TTTAGCTCCT AGCAACCATA TCCAAAACAA AGGAAGCAAA 1260
CCCTTGTATT TACCTACAGG AAATAGAAAG ATGCAGGTCT GGCTGTTGAT CACTGATTCC 1320
ACCATGAGCC AGAAAATTTT ACTTCATTTG GCCAAACCCC GGGACAGTTC AGTAGGGATT 1380
GCTGTTGACA CAAATAGGGG TTCCAGTTCC CACTGTTAAC TAACCACTTG GCCTTGGCAA 1440
GTCACTTCAT TTCTCTGGGC CTCAGTTTCC TCATCTGTAA AATGAGGCCT CTGGGCTTCA 1500
TGATCTCTTA GGTTTCCTGG TTCACAACTA GGAAAATGCT AAGATAAAGG TATAGGTATA 1560
AACATCTTTA AAAAGTCAGA AAAACATCTA TAACATTTCA AAAGAACAAT CTCTAGTGGA 1620
TAAAAATATG TGTACAGTAC AGTTGACTCA GCAATTTCAC TCAGAGTTTT ATCCTAAGGA 1680
AACAATCACA GATATGCTTC AAGATACAAG GATTGACGGG CGTGGTGGCT CATGCCTATA 1740
ATCCCAGCAC TTTGGGAGGC 1760
|
